National Healthcare

NHC Reports 2023 Year End Earnings

Retrieved on: 
Friday, February 16, 2024
Nursing, Practice Management, Managed Care, Health, General Health, Seniors, Pharmaceutical, Mental Health, Family, Hospitals, Consumer, National Healthcare, Table, GAAP, Government, NHC, Cryptocurrency

For the year ended December 31, 2023, the reported GAAP net income attributable to NHC was $66,798,000 compared to $22,445,000 for the 2022 year.

Key Points: 
  • For the year ended December 31, 2023, the reported GAAP net income attributable to NHC was $66,798,000 compared to $22,445,000 for the 2022 year.
  • GAAP diluted earnings per share were $4.34 compared to $1.45 for the years ended December 31, 2023 and 2022, respectively.
  • Adjusted diluted earnings per share were $3.55 compared to $2.42 for the years ended December 31, 2023 and 2022, respectively (*).
  • Adjusted diluted earnings per share were $1.03 compared to $0.72 for the quarters ended December 31, 2023 and 2022, respectively (*).

NHC Announces Common Dividend

Retrieved on: 
Friday, February 9, 2024
Nursing, Health, Consumer, Hospitals, Seniors, Managed Care, General Health, NHC, National Healthcare

National HealthCare Corporation (NYSE American: NHC), the nation’s oldest publicly traded long-term health care company, announced today that it will pay a quarterly dividend of 59 cents per common share to shareholders of record on March 29, 2024 and payable on May 1, 2024.

Key Points: 

National HealthCare Corporation (NYSE American: NHC), the nation’s oldest publicly traded long-term health care company, announced today that it will pay a quarterly dividend of 59 cents per common share to shareholders of record on March 29, 2024 and payable on May 1, 2024.

MatrixCare Forges Strategic Partnership with Tranzion, a Subsidiary of NHC, to Expand EHR Services for Senior Living Medical Providers

Retrieved on: 
Monday, January 29, 2024
Artificial intelligence, National Healthcare, Health, Partnership, Long-term care, NHC, Electronic health record, Machine learning, Senior living, EHR

Through this partnership, MatrixCare will provide Tranzion with cutting-edge Electronic Health Record (EHR) technology, including artificial intelligence (AI) and machine learning (ML), to help meet the need for EHR services in the senior living market.

Key Points: 
  • Through this partnership, MatrixCare will provide Tranzion with cutting-edge Electronic Health Record (EHR) technology, including artificial intelligence (AI) and machine learning (ML), to help meet the need for EHR services in the senior living market.
  • This collaboration will not only enhance Tranzion's service offerings but also inspire innovation across various sectors, including IT services, and clinical consulting on an ad-hoc basis.
  • Together, we're positioned to usher in a transformative era in senior living and long-term care, enhancing both patient outcomes and operational efficiency through cutting-edge technology."
  • With MatrixCare's support, Tranzion is poised to deliver comprehensive technology solutions that empower senior living and long-term care providers to excel in an evolving healthcare landscape.

59 Tristate Hospitals Unite for "It Doesn't Kill to Ask" Child Gun Safety Campaign

Retrieved on: 
Thursday, January 18, 2024
Death, Food, Hope, Hospital, Health, Northwell Health, Traffic, Suicide, Pet, Cancer, Gun violence, Public, Firearm, Nursing, Gun, Safety, Caregiver, Child, National Healthcare, Violence, Parent, Research, Physician

PHILADELPHIA, Jan. 18, 2024 /PRNewswire/ -- With firearms remaining the leading cause of injury and death in children, the nation's largest regional collaboration of health systems, representing 59 hospitals in Philadelphia, Southeastern Pennsylvania, Delaware and Southern New Jersey, is kicking off the year with a public service campaign that encourages a community approach to protecting children from unlocked guns.

Key Points: 
  • HospitalsTogether.com is the new name and website for the coalition's ongoing multi-media campaign called "It Doesn't Kill to Ask."
  • The campaign empowers caregivers, parents and community members to speak up about safe gun storage in homes a child might visit, providing actionable tools and new resources to aid in the process.
  • Given the importance of the gun safety public service message across the region, these hospitals and health systems are united in facing this crisis together.
  • Founded and led by national healthcare leader Rhoda Weiss, Ph.D., the expanded coalition partnered with Northwell Health, New York State's largest health system, in leading the gun safety effort.

China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL

Retrieved on: 
Wednesday, December 13, 2023
Marketing, Shanghai Stock Exchange, Quality of life, Epilepsy, A&B, Peptide, Absorption, National Healthcare, Methotrexate, National Healthcare Security Administration, Insurance, Safety, Tetrabenazine, Heart failure, CMS, Protein, Light, Recombinant, Acute decompensated heart failure, Sun Pharma, Nasal mucosa, PASI, Tablet, Patient, Psoriasis, Chemokine, Diazepam, Huntington's disease, Sale, Social Security, Tildrakizumab, Social, Vitamin E

China Medical System actively responds to national policies to promote innovative products to be included in the NRDL.

Key Points: 
  • China Medical System actively responds to national policies to promote innovative products to be included in the NRDL.
  • In addition, innovative drug Methotrexate Injection (Metoject) indicated for psoriasis approved in March 2023 has been included in category A of the National Reimbursement Drug List.
  • It is the first nasal spray formulation of diazepam in China and the first drug approved in China for the treatment of seizure clusters.
  • CMS actively responds to national policies to promote innovative products to be included in the National Reimbursement Drug List.

NHC Reports Third Quarter 2023 Earnings

Retrieved on: 
Friday, November 3, 2023
Mental Health, Nursing, Seniors, Practice Management, Physical Therapy, Managed Care, Health, Consumer, General Health, National Healthcare, Table, GAAP, NYSE, NHC

National HealthCare Corporation (NYSE American: NHC ), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the quarter ended September 30, 2023 totaled $288,485,000 compared to $270,843,000 for the quarter ended September 30, 2022, an increase of 6.5%.

Key Points: 
  • National HealthCare Corporation (NYSE American: NHC ), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the quarter ended September 30, 2023 totaled $288,485,000 compared to $270,843,000 for the quarter ended September 30, 2022, an increase of 6.5%.
  • For the quarter ended September 30, 2023, the reported GAAP net income attributable to NHC was $10,388,000 compared to a net loss of $2,429,000 for the same period in 2022.
  • The GAAP diluted earnings per share was $0.68 for the quarter ended September 30, 2023 compared to a loss per share of $(0.16) for the quarter ended September 30, 2022.
  • Adjusted diluted earnings per share were $0.86 and $0.50 for the quarters ended September 30, 2023 and 2022, respectively (*).

NHC Announces Common Dividend

Retrieved on: 
Thursday, November 2, 2023
Nursing, Health, Consumer, Hospitals, Seniors, General Health, National Healthcare, NYSE, NHC, Pharmaceutical industry

National HealthCare Corporation (NYSE American: NHC), the nation’s oldest publicly traded long-term health care company, announced today that it will pay a quarterly dividend of 59 cents per common share to shareholders of record on December 29, 2023 and payable on February 1, 2024.

Key Points: 

National HealthCare Corporation (NYSE American: NHC), the nation’s oldest publicly traded long-term health care company, announced today that it will pay a quarterly dividend of 59 cents per common share to shareholders of record on December 29, 2023 and payable on February 1, 2024.

Amedisys Celebrates National Quality Week

Retrieved on: 
Wednesday, October 18, 2023
National Association, HCI, Organization, Senior, Contessa, National Healthcare, Health, Palliative care, Patient, Patient safety, Hospice, CMS, Star, Nursing, Amedisys

During National Quality Week, Amedisys will focus on the importance of quality in healthcare by raising awareness among healthcare professionals and patients.

Key Points: 
  • During National Quality Week, Amedisys will focus on the importance of quality in healthcare by raising awareness among healthcare professionals and patients.
  • Amedisys Hospice outperformed the national average in all seven quality measures of the Hospice Item Set (HIS) in the CMS August 2023 preview report.
  • "National Quality Week provides us with a platform to showcase our unwavering dedication to quality and reinforces our commitment to delivering exceptional healthcare services to our patients.
  • Congratulations to our outstanding clinicians for their dedication to clinical distinction and quality.”
    The National Healthcare Quality Week was established by the National Association of Healthcare Quality in 1985, among other things, to recognize and celebrate the contribution of healthcare quality experts in their various organizations.

CPL Welcomes Ryan Daniels to Lead Healthcare Efforts in Florida

Retrieved on: 
Thursday, September 14, 2023
Volunteering, HCD, Society, LEED AP, Agency for Health Care Administration, CPL, Cancer, AAH, CLC, Rehabilitation, SMPS, AGC, AdventHealth, BJC HealthCare, AHCA, Hospital, Daniels, NCARB, National Healthcare, Patient, BJC, Agency, Mercy, Humanity, Associated, H. Lee Moffitt Cancer Center & Research Institute, American Institute, Conference, AIA, Associated General Contractors of America, Interior design, Nursing

In this pivotal role, he will facilitate CPL's expansion into the Florida healthcare market to address regional gaps in service and expertise.

Key Points: 
  • In this pivotal role, he will facilitate CPL's expansion into the Florida healthcare market to address regional gaps in service and expertise.
  • Drawing from experience spanning two decades, Daniels will enhance CPL's healthcare practice and assemble a FL team.
  • Counted among his noteworthy clients are Moffitt Cancer Center , AdventHealth , Lakeland Regional Health , Baptist Health Jax , BJC HealthCare and the Mercy healthcare system.
  • CPL looks forward to bringing Daniels' unique blend of design vision and extensive industry healthcare knowledge to clients in Florida and across the country.

Hua Medicine Announces 2023 Interim Results

Retrieved on: 
Friday, August 25, 2023
IGT, DREAM, National Healthcare Security Administration, Rat, Type 2 diabetes, Diabetes, Obesity, Progress, Hong Kong Exchanges and Clearing, Hospital, Patient, NGT, Fructose, American Diabetes Association, ADA, Disease, Pharmacy, Drug discovery, DSM-IV codes, Pancreas, Research, Homeostasis, Kidney, PPG, FKI, Liver, Growth, IND, Fatty liver disease, Endocrinology, DPP-4, Stroke, Chinese University of Hong Kong, MAH, Type 2, Metformin, CUHK, IVD, STA, DKD, Glucokinase, Probability, Metabolism, Liver disease, GK, Nature Communications, SEED, Trial of the century, TIR, Plasma protein binding, GKA, National Healthcare, Physician, AI, Bank, NRDL, Medicine, Congenital hyperinsulinism, Medical device, Pharmaceutical industry, Cryptocurrency, Bayer, T2D

Hua Medicine (the "Company", HKEx: 2552) today announces the unaudited consolidated results of the Company and its subsidiaries for the six months ended June 30, 2023 (the "Reporting Period").

Key Points: 
  • Hua Medicine (the "Company", HKEx: 2552) today announces the unaudited consolidated results of the Company and its subsidiaries for the six months ended June 30, 2023 (the "Reporting Period").
  • Dr. Li Chen, the founder and CEO of Hua Medicine, said, "the first half of 2023 was a critical stage for Hua Medicine to begin commercialization.
  • The revenue of Hua Medicine for the first half of 2023 was RMB70.3 million, which was an increase of approximately 299.6% comparing to the second half of 2022.
  • This article contains the statements regarding the future expectations, plans and prospects for Hua Medicine and the investigational product.